PH22471A - Acetyl erythromycin stearate and compositions containing it - Google Patents
Acetyl erythromycin stearate and compositions containing itInfo
- Publication number
- PH22471A PH22471A PH31689A PH31689A PH22471A PH 22471 A PH22471 A PH 22471A PH 31689 A PH31689 A PH 31689A PH 31689 A PH31689 A PH 31689A PH 22471 A PH22471 A PH 22471A
- Authority
- PH
- Philippines
- Prior art keywords
- compositions containing
- erythromycin stearate
- acetyl erythromycin
- acetyl
- stearate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK5884A DK149776C (da) | 1984-01-06 | 1984-01-06 | Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH22471A true PH22471A (en) | 1988-09-12 |
Family
ID=8089251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH31689A PH22471A (en) | 1984-01-06 | 1985-01-07 | Acetyl erythromycin stearate and compositions containing it |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US4599326A (el) |
| JP (1) | JPS60158197A (el) |
| KR (1) | KR900006237B1 (el) |
| AT (1) | AT386414B (el) |
| AU (1) | AU565688B2 (el) |
| BE (1) | BE901411A (el) |
| BG (1) | BG43189A3 (el) |
| CA (1) | CA1224461A (el) |
| CH (1) | CH666275A5 (el) |
| CS (1) | CS247191B2 (el) |
| CY (1) | CY1462A (el) |
| DE (1) | DE3500179A1 (el) |
| DK (1) | DK149776C (el) |
| ES (1) | ES8605818A1 (el) |
| FI (1) | FI77249C (el) |
| FR (1) | FR2557878B1 (el) |
| GB (1) | GB2152502B (el) |
| HK (1) | HK11590A (el) |
| HU (1) | HU196221B (el) |
| IE (1) | IE57967B1 (el) |
| IL (1) | IL73885A (el) |
| IS (1) | IS2968A7 (el) |
| IT (1) | IT1184304B (el) |
| KE (1) | KE3841A (el) |
| LU (1) | LU85721A1 (el) |
| MA (1) | MA20316A1 (el) |
| MX (1) | MX156277A (el) |
| NL (1) | NL8403979A (el) |
| NO (1) | NO160263C (el) |
| NZ (1) | NZ210606A (el) |
| PH (1) | PH22471A (el) |
| PL (1) | PL144349B1 (el) |
| PT (1) | PT79777B (el) |
| RO (1) | RO91262B (el) |
| SE (1) | SE461854B (el) |
| SU (1) | SU1410866A3 (el) |
| YU (1) | YU44485B (el) |
| ZA (1) | ZA8410143B (el) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874614A (en) * | 1985-03-25 | 1989-10-17 | Abbott Laboratories | Pharmaceutical tableting method |
| US4863741A (en) * | 1985-03-25 | 1989-09-05 | Abbott Laboratories | Tablet composition for drug combinations |
| JP3382159B2 (ja) * | 1998-08-05 | 2003-03-04 | 株式会社東芝 | 情報記録媒体とその再生方法及び記録方法 |
| AU2003247876B2 (en) * | 2002-07-05 | 2006-10-05 | Collegium Pharmaceutical, Inc | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| JP2007509974A (ja) * | 2003-10-31 | 2007-04-19 | アルザ・コーポレーシヨン | ３−アミノプロピル−ｎ−ブチルホスフィン酸の増大した吸収のための組成物および薬用量形態 |
| PT1765292T (pt) | 2004-06-12 | 2017-12-29 | Collegium Pharmaceutical Inc | Formulações de fármacos dissuasoras de abuso |
| WO2006025882A2 (en) | 2004-08-25 | 2006-03-09 | The Uab Research Foundation | Absorption enhancers for drug administration |
| US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
| EP2158898A1 (en) | 2006-06-23 | 2010-03-03 | Aegis Therapeutics LLC | Stabilizing alkylglycoside compositions and method thereof |
| US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| KR102512178B1 (ko) | 2011-05-18 | 2023-03-20 | 메더리스 다이어비티즈, 엘엘씨 | 개선된 펩티드 제약 |
| KR102213907B1 (ko) | 2012-11-20 | 2021-02-09 | 메더리스 다이어비티즈, 엘엘씨 | 인슐린 저항성에 대한 개선된 펩티드 약제 |
| CA3157899A1 (en) | 2012-11-20 | 2014-05-30 | Mederis Diabetes, Llc | Improved peptide pharmaceuticals |
| WO2014140699A1 (en) * | 2013-03-13 | 2014-09-18 | Calyx Chemicals And Pharmaceuticals Ltd | A novel process of liberation of erythromycin and preparation of its salts |
| WO2015184177A1 (en) | 2014-05-28 | 2015-12-03 | Mederis Diabetes, Llc | Improved peptide pharmaceuticals for insulin resistance |
| US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
| JP6938682B2 (ja) | 2017-05-19 | 2021-09-22 | ルネラ・バイオテック・インコーポレーテッド | アンチミトシン：癌幹細胞を根絶するためのミトコンドリア生合成の標的阻害薬 |
| WO2019108729A1 (en) | 2017-12-01 | 2019-06-06 | Lunella Biotech, Inc. | Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| JP6941224B2 (ja) | 2018-02-06 | 2021-09-29 | イージス セラピューティクス，エルエルシー | 疾患の処置のための鼻腔内エピネフリン製剤及び方法 |
| CN116549389A (zh) | 2018-02-06 | 2023-08-08 | 爱奇司治疗公司 | 鼻内肾上腺素制剂及治疗疾病的方法 |
| CA3123838A1 (en) * | 2018-12-17 | 2020-06-25 | Lunella Biotech, Inc. | Triple combination therapies for targeting mitochondria and killing cancer stem cells |
| JP2022514739A (ja) * | 2018-12-17 | 2022-02-15 | ルネラ・バイオテック・インコーポレーテッド | 抗加齢のための三剤組合せ療法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1179208A (fr) * | 1953-11-16 | 1959-05-21 | Abbott Lab | Procédé de préparation de sels d'érythromycine |
| DE1011117B (de) * | 1953-11-16 | 1957-06-27 | Abbott Lab | Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen |
| GB834397A (en) * | 1958-07-29 | 1960-05-04 | Lilly Co Eli | Therapeutic compositions comprising erythromycin esters |
| US4150220A (en) * | 1977-02-04 | 1979-04-17 | Pfizer Inc. | Semi-synthetic 4"-erythromycin A derivatives |
| FR2473525A1 (fr) * | 1980-01-11 | 1981-07-17 | Roussel Uclaf | Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1984
- 1984-01-06 DK DK5884A patent/DK149776C/da not_active IP Right Cessation
- 1984-12-18 NZ NZ210606A patent/NZ210606A/en unknown
- 1984-12-20 IL IL73885A patent/IL73885A/xx not_active IP Right Cessation
- 1984-12-21 AU AU37059/84A patent/AU565688B2/en not_active Ceased
- 1984-12-21 GB GB08432368A patent/GB2152502B/en not_active Expired
- 1984-12-27 US US06/686,753 patent/US4599326A/en not_active Expired - Fee Related
- 1984-12-28 ZA ZA8410143A patent/ZA8410143B/xx unknown
- 1984-12-28 PT PT79777A patent/PT79777B/pt not_active IP Right Cessation
- 1984-12-28 IS IS2968A patent/IS2968A7/is unknown
- 1984-12-28 BE BE0/214265A patent/BE901411A/fr not_active IP Right Cessation
- 1984-12-28 SE SE8406671A patent/SE461854B/sv not_active IP Right Cessation
- 1984-12-31 NL NL8403979A patent/NL8403979A/nl not_active Application Discontinuation
-
1985
- 1985-01-02 NO NO850007A patent/NO160263C/no unknown
- 1985-01-02 MA MA20540A patent/MA20316A1/fr unknown
- 1985-01-02 FR FR8500005A patent/FR2557878B1/fr not_active Expired
- 1985-01-03 AT AT0000985A patent/AT386414B/de not_active IP Right Cessation
- 1985-01-03 FI FI850023A patent/FI77249C/fi not_active IP Right Cessation
- 1985-01-04 YU YU20/85A patent/YU44485B/xx unknown
- 1985-01-04 CS CS8596A patent/CS247191B2/cs unknown
- 1985-01-04 PL PL1985251457A patent/PL144349B1/pl unknown
- 1985-01-04 LU LU85721A patent/LU85721A1/fr unknown
- 1985-01-04 IE IE22/85A patent/IE57967B1/en not_active IP Right Cessation
- 1985-01-04 IT IT19012/85A patent/IT1184304B/it active
- 1985-01-04 KR KR1019850000008A patent/KR900006237B1/ko not_active IP Right Cessation
- 1985-01-04 HU HU8537A patent/HU196221B/hu not_active IP Right Cessation
- 1985-01-04 ES ES539349A patent/ES8605818A1/es not_active Expired
- 1985-01-04 CA CA000471563A patent/CA1224461A/en not_active Expired
- 1985-01-04 CH CH31/85A patent/CH666275A5/de not_active IP Right Cessation
- 1985-01-04 SU SU853836820A patent/SU1410866A3/ru active
- 1985-01-04 DE DE19853500179 patent/DE3500179A1/de active Granted
- 1985-01-05 BG BG068285A patent/BG43189A3/xx unknown
- 1985-01-07 JP JP60000744A patent/JPS60158197A/ja active Granted
- 1985-01-07 MX MX203973A patent/MX156277A/es unknown
- 1985-01-07 RO RO117230A patent/RO91262B/ro unknown
- 1985-01-07 PH PH31689A patent/PH22471A/en unknown
-
1988
- 1988-10-28 KE KE3841A patent/KE3841A/xx unknown
-
1989
- 1989-07-21 CY CY1462A patent/CY1462A/xx unknown
-
1990
- 1990-02-15 HK HK115/90A patent/HK11590A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH22471A (en) | Acetyl erythromycin stearate and compositions containing it | |
| NZ213463A (en) | Antibiotic compound and compositions | |
| PH24830A (en) | Indolize compounds and compositions containing them | |
| GB2165751B (en) | Pharmaceutical compositions containing anthracycline glycosides | |
| IL74758A (en) | Acyltripeptides and pharmaceutical compositions containing them | |
| NZ211145A (en) | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions | |
| IL89996A0 (en) | Macrolide compositions | |
| GB8401016D0 (en) | Organopolysiloxane compositions | |
| NZ212005A (en) | Pyrrolobenzimidazoles and pharmaceutical compositions | |
| ZA859339B (en) | Processes and compositions | |
| EP0214102A3 (en) | 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions | |
| NZ211872A (en) | Chartreusin derivatives and antitumorous compositions | |
| AU519743B2 (en) | Compositions containing erythromycin and metoclopramide | |
| EP0230052A3 (en) | Immunoamplifiers and related compositions | |
| EP0210655A3 (en) | Polystyrene compositions | |
| PH23343A (en) | 8 0( acylaminoergolines and pharmaceutical compositions containing them | |
| IL74667A (en) | Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them | |
| GB8514485D0 (en) | Organopolysiloxane compositions | |
| GB2205746B (en) | Beta-glucuronidase containing compositions | |
| NZ219645A (en) | Pyrazoles and gametocidal compositions | |
| GB8507710D0 (en) | Acetyl compound | |
| IE830409L (en) | Oleandomycin and erythromycin derivatives | |
| GB8500263D0 (en) | 4'-deoxy-4'-halodoxorubicin-14-esters | |
| NZ212112A (en) | Tetrahydronaphthalenols and pharmaceutical compositions | |
| IE842007L (en) | Erythromycine and irosine compositions |